Bridging the divide: global inequities in access to HIV/AIDS therapy

Dore, Gregory J; Cooper, David A

Editorial

Correspondence:

1.
Delta Coordinating Committee. Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. Lancet 1996; 348: 283-291.
2.
CAESAR Coordinating Committee. Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial. Lancet 1997; 349: 1413-1421.
3.
Montaner JS, Reiss P, Cooper D, et al. A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada, and Australia Study. JAMA 1998; 279: 930-937.
4.
Danner SA, Carr A, Leonard JM, et al. A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group. N Engl J Med 1995; 333: 1528-1533.
5.
Bozzette SA, Joyce G, McCaffrey DF, et al. Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy. N Engl J Med 2001; 334: 817-823.
6.
Joint United Nations Programme on HIV/AIDS. AIDS epidemic update: December 2000. Geneva: Joint United Nations Programme on HIV/AIDS, 2000.
7.
Attaran A, Gillespie-White L. Do patents for antiretroviral drugs constrain access to AIDS treatment in Africa? JAMA 2001; 286: 1886-1892.
8.
Declaration of Commitment on HIV/AIDS: "Global crisis - global action. <www.un.org/ga/aids/coverage/FinalDeclarationHIVAIDS.html> Accessed, Sep 2001.
9.
Gottlieb S. US concedes on cheaper drug production in Brazil. BMJ 2001; 323: 12.
10.
Horton R. African AIDS beyond Mbeki: tripping into anarchy. Lancet 2000; 356: 1541-1542.
11.
Harries AD, Nyangulu DS, Hargreaves NJ, et al. Preventing antiretroviral anarchy in sub-Saharan Africa. Lancet 2001; 358: 410-414.
12.
Grant AD, Djomand G, De Cock KM. Natural history and spectrum of disease in adults with HIV/AIDS in Africa. AIDS 1997; 11 Suppl B: S43-S54.
13.
Kroon ED, Ungsedhapand C, Ruxrungtham, et al. A randomized, double-blind trial of half versus standard dose of zidovudine plus zalcitabine in Thai HIV-1-infected patients (study HIV-NAT 001). HIV Netherlands Australia Thailand Research Collaboration. AIDS 2000; 14: 1349-1356.
14.
National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia. Annual surveillance report 2001. Sydney: National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, 2001.
15.
World Health Organization, Western Pacific Region. STD/HIV/AIDS surveillance report, no. 10. Manila: WHO, October 1997.

Online responses are no longer available. Please refer to our instructions for authors page for more information.